Supernus Pharmaceuticals
SUPN
SUPN
272 hedge funds and large institutions have $1.71B invested in Supernus Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 92 increasing their positions, 99 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% less capital invested
Capital invested by funds: $1.81B → $1.71B (-$100M)
6% less funds holding
Funds holding: 289 → 272 (-17)
28% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 47
Holders
272
Holding in Top 10
1
Calls
$11.5M
Puts
$9.79M
Top Buyers
| 1 | +$19.1M | |
| 2 | +$11.6M | |
| 3 | +$9.88M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$9.12M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$8.22M |
Top Sellers
| 1 | -$15.9M | |
| 2 | -$7.96M | |
| 3 | -$6.42M | |
| 4 |
MFIMFI
Mesirow Financial Investment Management - Fixed Income
Chicago,
Illinois
|
-$5.74M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$5.03M |